Protein kinase C delta stimulates apoptosis by initiating G1 phase cell cycle progression and S phase arrest.
Overexpression of protein kinase C delta (PKCdelta) stimulates apoptosis in a wide variety of cell types through a mechanism that is incompletely understood. PKCdelta-deficient cells are impaired in their response to DNA damage-induced apoptosis, suggesting that PKCdelta is required to mount an appropriate apoptotic response under conditions of stress. The mechanism through which it does so remains elusive. In addition to effects on cell survival, PKCdelta elicits pleiotropic effects on cellular proliferation. We now provide the first evidence that the ability of PKCdelta to stimulate apoptosis is intimately linked to its ability to stimulate G(1) phase cell cycle progression. Using an adenoviral-based expression system to express PKCalpha,-delta, and -epsilon in epithelial cells, we demonstrate that a modest increase in PKCdelta activity selectively stimulates quiescent cells to initiate G(1) phase cell cycle progression. Rather than completing the cell cycle, PKCdelta-infected cells arrest in S phase, an event that triggers caspase-dependent apoptotic cell death. Apoptosis was preceded by the activation of cell cycle checkpoints, culminating in the phosphorylation of Chk-1 and p53. Strikingly, blockade of S phase entry using the phosphatidylinositol 3-kinase inhibitor LY294002 prevented checkpoint activation and apoptosis. In contrast, inhibitors of mitogen-activated protein kinase cascades failed to prevent apoptosis. These findings demonstrate that the biological effects of PKCdelta can be extended to include positive regulation of G(1) phase cell cycle progression. Importantly, they reveal the existence of a novel, cell cycle-dependent mechanism through which PKCdelta stimulates cell death.
Santiago-Walker
Ademi E
AE
Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, 19104-6061, USA.
Fikaris
Aphrothiti J
AJ
Kao
Gary D
GD
Brown
Eric J
EJ
Kazanietz
Marcelo G
MG
Meinkoth
Judy L
JL
D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D017209:Apoptosis; D015153:Blotting, Western; D001973:Bromodeoxyuridine / Q000494:pharmacology; D002453:Cell Cycle; D016923:Cell Death; D049109:Cell Proliferation; D000071877:Checkpoint Kinase 1; D002867:Chromones / Q000494:pharmacology; D004247:DNA / Q000378:metabolism; D004249:DNA Damage; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004847:Epithelial Cells / Q000378:metabolism; D005434:Flow Cytometry; D016193:G1 Phase; D008954:Models, Biological; D009025:Morpholines / Q000494:pharmacology; D010766:Phosphorylation; D011493:Protein Kinase C / Q000378:metabolism / Q000502:physiology*; D051745:Protein Kinase C-delta; D011494:Protein Kinases / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D016196:S Phase; D013961:Thyroid Gland / Q000166:cytology; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism; D015854:Up-Regulation
D002867:Chromones; D004791:Enzyme Inhibitors; D009025:Morpholines; D016159:Tumor Suppressor Protein p53; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; D004247:DNA; D011494:Protein Kinases; C497260:Prkcd protein, rat; D000071877:Checkpoint Kinase 1; D011493:Protein Kinase C; D051745:Protein Kinase C-delta; D001973:Bromodeoxyuridine